410919000: Drospirenone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Sex hormone (substance)\Progesterone receptor agonist\Synthetic progestogen (substance)\Drospirenone (substance)
\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Steroid hormone\Mineralocorticoid\Drospirenone (substance)
\Substance categorized by disposition\Receptor agonist\Progesterone receptor agonist\Synthetic progestogen (substance)\Drospirenone (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Steroid\...

\Corticosteroid and/or corticosteroid derivative\Mineralocorticoid\Drospirenone (substance)

\Steroid hormone\Mineralocorticoid\Drospirenone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Drospirenone (substance)	Is a	Progesterone	false	Inferred relationship	Some
Drospirenone (substance)	Is a	Synthetic progestogen (substance)	true	Inferred relationship	Some
Drospirenone (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Progestational hormone	false	Inferred relationship	Some
Drospirenone (substance)	Is a	Steroid hormone	false	Inferred relationship	Some
Drospirenone (substance)	Is a	Mineralocorticoid	true	Inferred relationship	Some
Drospirenone (substance)	Is a	Progestational hormone	false	Inferred relationship	Some
Drospirenone (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Progesterone receptor agonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Drospirenone (substance)	Inferred relationship	Some
Product containing drospirenone and ethinylestradiol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 2 mg and estradiol 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Drospirenone (substance)	Inferred relationship	Some
Product containing drospirenone and estradiol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 500 microgram and estradiol 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Drospirenone (substance)	Inferred relationship	Some
Product containing drospirenone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	1
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Drospirenone (substance)	Inferred relationship	Some
Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Drospirenone (substance)	Inferred relationship	Some
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Drospirenone (substance)	Inferred relationship	Some	2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 500 microgram and estradiol 1 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Drospirenone (substance)	Inferred relationship	Some	1
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Drospirenone (substance)	Inferred relationship	Some	1
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Drospirenone (substance)	Inferred relationship	Some	1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Drospirenone (substance)	Inferred relationship	Some	1
Drospirenone 2 mg and estradiol 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 2 mg and estradiol 1 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 500 microgram and estradiol 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 500 microgram and estradiol 1 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Drospirenone (substance)	Inferred relationship	Some	2
Product containing only ethinylestradiol 0.03 milligram and drospirenone 3 milligram/1 each oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Drospirenone (substance)	Inferred relationship	Some	2
Product containing only ethinylestradiol 0.03 milligram and drospirenone 3 milligram/1 each oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Drospirenone (substance)	Inferred relationship	Some	1
Drospirenone- and estradiol-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Product containing drospirenone and ethinylestradiol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 2 mg and estradiol 1 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Drospirenone (substance)	Inferred relationship	Some	2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Drospirenone (substance)	Inferred relationship	Some	1
Drospirenone 500 microgram and estradiol 1 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Drospirenone (substance)	Inferred relationship	Some	1
Drospirenone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	1
Product containing only drospirenone and estradiol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone and ethinylestradiol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone and estradiol only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Product containing only drospirenone and ethinylestradiol and levomefolic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Drospirenone (substance)	Inferred relationship	Some	2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone and ethinylestradiol and levomefolic acid only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 500 microgram and estradiol 1 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Drospirenone (substance)	Inferred relationship	Some	2
Product containing precisely drospirenone 3 milligram and estetrol 14.2 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Drospirenone (substance)	Inferred relationship	Some	2
Product containing precisely drospirenone 3 milligram and estetrol 14.2 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone- and estetrol-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone and estetrol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone- and estetrol-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone and estetrol only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Drospirenone (substance)	Inferred relationship	Some	2
Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Drospirenone (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2466370019	Drospirenone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2472566012	Drospirenone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
52971000195117	drospirenone	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
807661000172115	drospirénone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
67841000195113	Drospirenon	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module